Panmycin: Broad-Spectrum Antibiotic for Effective Bacterial Infection Control
Panmycin
| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.37 | $41.00 (0%) | π Add to cart |
| 60 | $0.98 | $82.00 $59.00 (28%) | π Add to cart |
| 90 | $0.83 | $123.00 $75.00 (39%) | π Add to cart |
| 120 | $0.77 | $164.00 $92.00 (44%) | π Add to cart |
| 180 | $0.71 | $246.00 $127.00 (48%) | π Add to cart |
| 270 | $0.66 | $369.00 $177.00 (52%) | π Add to cart |
| 360 | $0.63
Best per pill | $492.00 $228.00 (54%) | π Add to cart |
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.60 | $48.00 (0%) | π Add to cart |
| 60 | $1.12 | $96.00 $67.00 (30%) | π Add to cart |
| 90 | $0.97 | $144.00 $87.00 (40%) | π Add to cart |
| 120 | $0.88 | $192.00 $106.00 (45%) | π Add to cart |
| 180 | $0.81 | $288.00 $145.00 (50%) | π Add to cart |
| 270 | $0.75 | $432.00 $203.00 (53%) | π Add to cart |
| 360 | $0.72
Best per pill | $576.00 $260.00 (55%) | π Add to cart |
Similar products
Panmycin (Tetracycline Hydrochloride) is a time-tested, broad-spectrum antibiotic belonging to the tetracycline class, widely prescribed for its efficacy against a diverse range of gram-positive and gram-negative bacteria, rickettsiae, mycoplasma, and chlamydia. It functions by inhibiting bacterial protein synthesis at the ribosomal level, effectively halting microbial proliferation. Clinicians rely on Panmycin for its established therapeutic profile in treating respiratory, genitourinary, and dermatological infections, among others. Proper usage under medical supervision ensures optimal outcomes while minimizing resistance development.
Features
- Active ingredient: Tetracycline Hydrochloride 250 mg or 500 mg per capsule
- Broad-spectrum activity against aerobic and anaerobic bacteria
- High oral bioavailability with consistent absorption profiles
- Manufactured under strict GMP (Good Manufacturing Practice) standards
- Available in capsule form for convenient dosing
- Stable shelf life when stored appropriately
Benefits
- Effectively treats a wide array of bacterial infections, reducing symptom duration and severity
- Minimizes risk of complication progression when administered early in infection course
- Provides flexible dosing regimens adaptable to patient-specific factors like renal function
- Cost-effective therapeutic option compared to newer-generation antibiotics
- Well-documented efficacy in both community-acquired and certain nosocomial infections
- Supports combination therapy in complex or polymicrobial infections when clinically indicated
Common use
Panmycin is indicated for the treatment of infections caused by susceptible strains of microorganisms, including but not limited to: upper and lower respiratory tract infections (e.g., bronchitis, pneumonia); urinary tract infections; sexually transmitted infections such as chlamydia; skin and soft tissue infections; rickettsial diseases like Rocky Mountain spotted fever; and zoonotic infections including brucellosis (typically in combination with streptomycin). It is also used as an alternative agent in penicillin-allergic patients for syphilis treatment and for acne vulgaris management due to its anti-inflammatory and antibacterial effects on Cutibacterium acnes.
Dosage and direction
Dosage must be individualized based on infection severity, pathogen susceptibility, and patient renal function. For adults, the usual dose is 500 mg twice daily or 250 mg four times daily. For more severe infections, an initial dose of 500 mg followed by 250 mg every six hours may be prescribed. For children above eight years, the recommended dosage is 25β50 mg/kg/day divided into four equal doses. Administer Panmycin capsules with a full glass of water to reduce esophageal irritation and ulceration risk, preferably one hour before or two hours after meals to maximize absorption. Avoid concomitant administration with dairy products, antacids, or iron supplements, as these can significantly impair absorption. Treatment should continue for at least 24β48 hours after symptoms and fever have subsided; typically, a 7β14 day course is standard, thoughζδΊ infections may require extended therapy.
Precautions
Use with caution in patients with renal impairment; dosage adjustment may be necessary. Avoid use during tooth development (last trimester of pregnancy, infancy, childhood up to age 8) due to risk of permanent tooth discoloration and enamel hypoplasia. May cause photosensitivity; advise patients to limit sun exposure and use protective measures. Use with caution in patients with hepatic dysfunction. Superinfection (including candidiasis or Clostridioides difficile-associated diarrhea) may occur; monitor for new symptoms. Not recommended for meningococcal infection treatment due to inadequate cerebrospinal fluid penetration. Prolonged use may result in fungal or bacterial superinfection, including pseudomembranous colitis.
Contraindications
Hypersensitivity to tetracycline or any component of the formulation. Contraindicated in children under 8 years (except for serious infections where alternatives are not suitable or available, such as anthrax exposure). Do not use in patients with systemic lupus erythematosus, as tetracyclines may exacerbate symptoms. Avoid during pregnancy due to fetal harm risk (including inhibition of bone growth and tooth discoloration). Contraindicated in breastfeeding women due to secretion in milk and potential effects on the infant.
Possible side effect
Common: nausea, vomiting, diarrhea, epigastric distress, glossitis, dysphagia, enterocolitis. Dermatological: photosensitivity, maculopapular rash. Less common: esophageal ulceration, hepatotoxicity (especially with high doses or in pregnancy), pseudotumor cerebri (benign intracranial hypertension), blood dyscrasias (e.g., hemolytic anemia, thrombocytopenia). Rare: anaphylaxis, angioedema, exacerbation of systemic lupus erythematosus, pancreatitis, tooth discoloration (in young patients). Long-term use: possible nephrogenic diabetes insipidus, lupus-like syndrome.
Drug interaction
Antacids containing aluminum, calcium, or magnesium; iron preparations; zinc salts; and bismuth subsalicylate: significantly decrease tetracycline absorption. Oral contraceptives: tetracyclines may reduce efficacy, increasing breakthrough bleeding and pregnancy risk. Warfarin: may potentiate anticoagulant effect; monitor INR closely. Retinoids: increased risk of pseudotumor cerebri. Penicillins: tetracyclines may interfere with bactericidal activity of penicillins; avoid concomitant use. Methoxyflurane: increased risk of nephrotoxicity. Diuretics: may increase blood urea nitrogen levels.
Missed dose
If a dose is missed, take it as soon as remembered unless it is almost time for the next scheduled dose. Do not double the dose to catch up. Resume the regular dosing schedule. Consistent administration is important to maintain effective antibiotic concentrations; irregular dosing may reduce efficacy and promote resistance.
Overdose
Symptoms may include nausea, vomiting, diarrhea, dizziness, and headache. In severe cases, hepatotoxicity or pancreatitis may occur. No specific antidote exists; management is supportive and symptomatic. Gastric lavage may be considered if ingestion was recent. Hemodialysis is not effective for removal. Contact a poison control center or seek emergency medical attention immediately.
Storage
Store at controlled room temperature (20β25Β°C or 68β77Β°F), in a tightly closed container, protected from light, moisture, and excessive heat. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. Do not transfer capsules to other containers, as exposure to humidity can degrade the product.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Panmycin is a prescription medication and should only be used under the supervision of a qualified healthcare professional. Always follow your prescribing physicianβs instructions and read the patient information leaflet provided with the medication. Do not self-diagnose or self-medicate. The manufacturer is not liable for any incorrect use or misinterpretation of this data.
Reviews
“Prescribed Panmycin for recurrent bronchitis after failure of first-line agents. Noted significant improvement within 72 hours, with full resolution in 10 days. Tolerated well with no GI upset when taken as directed.” β Dr. A. Reynolds, Infectious Disease Specialist
“Effective in moderate acne management with twice-daily dosing. Patients report reduced inflammation and lesion count within 4β6 weeks. Advise sunscreen due to photosensitivity risk.” β Dr. L. Torres, Dermatologist
“Used for uncomplicated chlamydial infections per CDC guidelines. High efficacy with single-course treatment; convenient dosing supports patient adherence.” β Clinical Study, J Antimicrob Chemother
“Caution in elderly patients with renal impairment; require dose adjustment. Still a valuable option when susceptibility is confirmed.” β Dr. M. Evans, Geriatric Pharmacotherapy